PROCARDIA XL Drug Patent Profile

Which patents cover Procardia Xl, and what generic alternatives are available?

Procardia Xl is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in PROCARDIA XL is nifedipine. There are thirty-nine drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Procardia Xl

A generic version of PROCARDIA XL was approved as nifedipine by ACTAVIS ELIZABETH on September 20^th, 1990.

Summary for PROCARDIA XL

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	165
Clinical Trials:	11
Patent Applications:	3,747
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for PROCARDIA XL
DailyMed Link:	PROCARDIA XL at DailyMed

See drug prices for PROCARDIA XL

See drug sales revenues for PROCARDIA XL

Recent Clinical Trials for PROCARDIA XL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medical College of Wisconsin	N/A
Icahn School of Medicine at Mount Sinai	Phase 4
High Risk Obstetrical Consultants	Early Phase 1

See all PROCARDIA XL clinical trials

Pharmacology for PROCARDIA XL

Drug Class	Dihydropyridine Calcium Channel Blocker
Mechanism of Action	Calcium Channel Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for PROCARDIA XL

C08CA	Dihydropyridine derivatives
C08C	SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
C08	CALCIUM CHANNEL BLOCKERS
C	Cardiovascular system

US Patents and Regulatory Information for PROCARDIA XL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-001	Sep 6, 1989	AB2	RX	Yes	No
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-002	Sep 6, 1989	AB2	RX	Yes	No
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-003	Sep 6, 1989	AB2	RX	Yes	Yes

Expired US Patents for PROCARDIA XL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-002	Sep 6, 1989
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-002	Sep 6, 1989
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-001	Sep 6, 1989
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-003	Sep 6, 1989
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-001	Sep 6, 1989
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-001	Sep 6, 1989
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-002	Sep 6, 1989

International Patents for PROCARDIA XL

See the table below for patents covering PROCARDIA XL around the world.

Country	Patent Number	Title	Estimated Expiration
New Zealand	206600	OSMOTIC DRUG DELIVERY DEVICE
France	2545721	DISPOSITIF OSMOTIQUE POUR LA LIBERATION DE MATIERES DANS UN MILIEU D'UTILISATION
Japan	S5750913	NIFEDIPIN-CONTAINING SOLID MEDICINE AND MANUFACTURE
Sweden	455918	OSMOTISK AVGIVNINGSANORDNING MED DUBBEL TERMODYNAMISK VERKAN
Japan	S5914446
Canada	1180277	MEDICAMENT SOLIDE CONTENANT DE LA NIFEDIPINE ET PROCEDE DE PREPARATION (SOLID MEDICAMENT FORMULATIONS CONTAINING NIFEDIPINE, AND PROCESSES FOR THEIR PREPARATION)
Argentina	226377	PROCEDIMIENTO PARA LA OBTENCION DE FORMULACIONES MEDICAMENTOSAS A BASE DE NIFEDIPINA